Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

369 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
No association of endothelial lipase and aldose reductase polymorphisms with proliferative diabetic retinopathy: Results of the French prospective multicenter REDIAGEN study.
Henry A, Boigelot T, Moura TF, Leclercq I, Barbe C, Thiery A, Djerada Z, Nazeyrollas P, Clavel C, Cornillet-Lefebvre P, Berrod JP, Creuzot-Garcher C, Meyer L, Gaucher D, Guerci B, Lenoble P, Milazzo S, Perone JM, Arndt C, Durlach V. Henry A, et al. Among authors: creuzot garcher c. Diabetes Metab. 2024 May;50(3):101533. doi: 10.1016/j.diabet.2024.101533. Epub 2024 Apr 1. Diabetes Metab. 2024. PMID: 38570135 No abstract available.
Nanotopography by chromatic confocal microscopy of the endothelium in Fuchs endothelial corneal dystrophy, pseudophakic bullous keratopathy and healthy corneas.
Vaitinadapoulé H, Poinard S, He Z, Pascale-Hamri A, Thomas J, Gain P, Thuret JY, Mascarelli F, Thuret G; French Fuchs Study Group (FFSG). Vaitinadapoulé H, et al. Br J Ophthalmol. 2023 Sep 15:bjo-2023-323297. doi: 10.1136/bjo-2023-323297. Online ahead of print. Br J Ophthalmol. 2023. PMID: 37714683
Prospective, Observational, Multicenter, Real-World Study of the Efficacy, Safety, and Pattern of Use of the Dexamethasone Intravitreal Implant in Diabetic Macular Edema in France: Short-Term Outcomes of LOUVRE 3.
Kodjikian L, Delcourt C, Creuzot-Garcher C, Massin P, Conrath J, Velard MÈ, Lassalle T, Pinchinat S, Dupont-Benjamin L. Kodjikian L, et al. Ophthalmol Ther. 2023 Jun;12(3):1671-1692. doi: 10.1007/s40123-023-00662-8. Epub 2023 Mar 26. Ophthalmol Ther. 2023. PMID: 36967448 Free PMC article.
Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life Experience.
Debourdeau E, Medard R, Chamard C, Nguyen V, Gabrielle PH, Creuzot-Garcher C, Allieu S, Gillies MC, Barthelmes D, Daien V; Fight Retinal Blindness! Study Group. Debourdeau E, et al. Ophthalmol Ther. 2023 Oct;12(5):2657-2670. doi: 10.1007/s40123-023-00758-1. Epub 2023 Jul 28. Ophthalmol Ther. 2023. PMID: 37505396 Free PMC article.
Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry.
Arnould L, Balsat E, Hashimoto Y, White A, Kong G, Dunn H, Fan L, Gabrielle PH, Bron AM, Creuzot-Garcher CP, Lawlor M. Arnould L, et al. Among authors: creuzot garcher cp. Br J Ophthalmol. 2024 May 24:bjo-2023-325077. doi: 10.1136/bjo-2023-325077. Online ahead of print. Br J Ophthalmol. 2024. PMID: 38789132
Reply to: Response from Australian Ophthalmological Surgical Trainees and Consultants to: Cataract Surgical Training in Europe: European Board of Ophthalmology Survey.
Bourcier T, Dhubhghaill SN, Yaïci R, Sanogo M, Lefebvre F, Aclimandos W, Asoklis R, Atilla H, Creuzot-Garcher C, Curtin D, Cvenkel B, Flanagan L, Kivelä TT, Costa RM, Priglinger S, Filipe HP, Stopa M, Strong B, Sturmer J, Tassignon MJ, Ivekovic R, Maino A. Bourcier T, et al. Among authors: creuzot garcher c. J Cataract Refract Surg. 2024 May 22. doi: 10.1097/j.jcrs.0000000000001490. Online ahead of print. J Cataract Refract Surg. 2024. PMID: 38776150 No abstract available.
369 results